Vaginal Bleeding After Menopause: What Your Body is Truly Telling You
You haven't had a period in three years. And this month, you bled. It's not your body remembering old habits. It's a clinical alert — and it warrants a prompt response.
Menopause is medically defined as 12 consecutive months without menstruation. Beyond this threshold, any vaginal bleeding — even minimal, even a single instance — is classified as postmenopausal bleeding (PMB) and requires a gynecological consultation without delay. In approximately 10% of cases, a serious pathology is identified. In 90% of cases, the origin is benign. But you cannot know without a clinical evaluation.
What postmenopausal bleeding really is — and why it's never "harmless"
In my clinical practice, I regularly hear the same phrase: "I didn't want to make a big deal out of it." A 51-year-old woman waits six weeks before consulting because she thinks it might be hormonal residue, an unimportant singularity. I understand where this reluctance comes from. But it is precisely this type of bleeding that should never wait.
Menopause is officially diagnosed after 12 consecutive months without periods. This simple definition has precise implications: once this milestone is passed, the endometrium — the tissue lining the inside of the uterus — should no longer behave like a cyclical mucous membrane. It should no longer bleed. Ever. So if you bleed after three years without periods, it's not your body waking up old hormonal habits. It's a signal that requires investigation.
These numbers are not meant to alarm. They are there to provide context. The good news is that the majority of causes are treatable and often not serious. The bad news is that you cannot distinguish harmless endometrial atrophy from early endometrial cancer without a clinical examination and appropriate investigations. No doctor can do it by eye. And neither can you.
All possible causes — from the most common to the most serious
What makes this subject clinically delicate — and which general medicine sometimes manages too quickly — is that benign and serious causes often present almost identically. Light, brown bleeding, occurring only once. This could be vaginal atrophy. It could also be very early-stage endometrial cancer, with an excellent prognosis if caught at that precise moment.
| Cause | Frequency | Urgency Level |
|---|---|---|
| Endometrial or vaginal atrophy | Most common benign cause | To be evaluated |
| Endometrial or cervical polyps | Very common, often benign | Close monitoring |
| Endometritis (uterine lining infection) | Less common | Antibiotic treatment |
| Endometrial hyperplasia | Less common — potentially precancerous | Active management |
| Uterine fibroids (less common after menopause) | Rare but possible | Monitoring |
| Endometrial cancer | ~10% of PMB | Urgent |
| Cervical or vaginal cancer | Less common | Urgent |
| HRT, tamoxifen, or anticoagulants | Common if on current treatment | Report to doctor |
| Urological or anorectal origin (confused with PMB) | Underestimated in consultation | Additional evaluation |
| Trauma or sexual assault | Always to be explored with tact | Immediate evaluation |
A clinical paradox that conventional medicine rarely explains: endometrial atrophy — an endometrium that drastically thins with falling estrogen levels — is the most common benign cause of PMB. Intuition would suggest that thinner tissue bleeds less. The opposite is true. A severely atrophied endometrium has fragile vascularization that can cause spontaneous, subtle contact bleeding, which perfectly mimics an abnormal signal without being so. But ruling it out without examination would be a major clinical error.
According to an analysis published in JAMA Internal Medicine (Clarke et al., 2018), which examined over 2,000 women with postmenopausal bleeding, endometrial atrophy accounts for 50 to 60% of identified causes. Endometrial polyps follow at approximately 15–20%. Endometrial cancer — which is also the most common gynecological cancer in industrialized countries — is found in 5 to 12% of cases, depending on the cohort, with a frequency that significantly increases with age and in the presence of certain risk factors: obesity, type 2 diabetes, nulliparity, and a history of polycystic ovary syndrome.
What your gynecologist will look to rule out — and how
The initial consultation for postmenopausal bleeding follows a fairly precise protocol. Knowing this protocol beforehand isn't about anticipating answers — it's about understanding why certain tests are requested and not leaving with unasked questions.
Transvaginal ultrasound: the starting point
The first-line reference examination is transvaginal ultrasound. It measures the thickness of the endometrium: the threshold generally accepted for a postmenopausal woman is 4 to 5 mm. Below this value, the risk of endometrial cancer is very low. Above it, further investigations are necessary. This is not an absolute rule — I have followed patients with an endometrial thickness of 3 mm and a polyp not visible on standard ultrasound — but it is the first clinical landmark.
Endometrial biopsy and hysteroscopy
When ultrasound reveals a structural abnormality or when bleeding persists without an identified cause, an endometrial biopsy is performed — a tissue sample taken in the office or as a day-case procedure. Hysteroscopy — visual exploration of the uterine cavity via the natural route — allows for both visualization and simultaneous biopsy. It's a procedure that sounds intimidating on paper but is very well tolerated in the vast majority of cases, often without general anesthesia.
What about the Pap smear?
If your last Pap smear was more than three years ago, your gynecologist will likely perform one during the same consultation. Cervical cancer remains exceptional in a woman whose previous Pap smears were normal — but menopause does not exempt you from screening.
Before your consultation
Note the precise date of the bleeding, its approximate abundance, its color (bright red, brown, pinkish), its duration, and whether you are taking hormone therapy or any other medication. This information immediately guides the diagnosis.
Questions to ask your doctor
What is my endometrial thickness on the ultrasound? Was a polyp or anomaly observed? Is a biopsy necessary? What is the usual waiting time for results?
Risk factors to mention
Obesity, type 2 diabetes, prolonged exposure to estrogen without progesterone (late menopause, early puberty), nulliparity, and a history of PCOS are data that modify the degree of investigation proposed.
Family history to report
Endometrial cancer, colorectal cancer, or Lynch syndrome in the family? Systematically report it — this can radically change the recommended monitoring protocol.
When hormone therapy or medication might be the cause
If you are on hormone replacement therapy (HRT), the situation is different — but no less monitored. Unexpected bleeding while on HRT can simply indicate a formulation imbalance, irregular absorption, or a need for dose adjustment. It can also indicate something else. The rule remains the same: it needs to be evaluated.
Tamoxifen — prescribed for the prevention of recurrence of certain hormone-dependent breast cancers — is a special case. It acts as an anti-estrogen on breast tissue, but exerts a pro-estrogenic effect on the endometrium. Women on tamoxifen have a significantly increased risk of endometrial polyps, hyperplasia, and endometrial cancer. Any vaginal bleeding while on tamoxifen must be reported immediately to the oncologist and gynecologist, without waiting for the next scheduled appointment.
A point I systematically discuss in consultation and which few doctors spontaneously mention: anticoagulants — including preventive dose aspirin and direct oral anticoagulants (DOACs) — can cause or amplify genital bleeding in postmenopausal women, especially in cases of associated vaginal atrophy. This is not a contraindication to these treatments — they are often vital — but it is a factor that must be included in the overall assessment.
What conventional medicine still integrates too little into this picture: non-gynecological origins of bleeding. Terminal hematuria during urination, bleeding of hemorrhoidal or rectal origin — these situations are underestimated in consultations, as they require the patient to carefully observe the precise context in which the bleeding occurs. A 48-hour clinical diary can save a lot of diagnostic time.
What you can do before your gynecological appointment
The absolute priority is to consult. Not in three weeks. This week. If your general practitioner cannot see you quickly, go to the gynecological emergency department of a maternity ward or hospital center. Postmenopausal bleeding is a legitimate reason for an urgent consultation — do not let politeness or fear of "bothering" delay an evaluation that can change a prognosis.
Note in a notebook: the date(s) of bleeding, its appearance (bright red, brown, pinkish), its relative abundance (a few traces on toilet paper, need for protection), its duration, associated pain if present, and whether sexual intercourse preceded the bleeding within 48 hours.
Avoid sexual intercourse until the gynecological examination: not because it caused the bleeding, but because contact bleeding can skew clinical interpretation during the examination.
Also prepare a complete list of your medications and food supplements — including phytoestrogens, adaptogenic herbal supplements, and any past or present hormone therapy.
What I often tell my patients: your body speaks to you in the only language it knows. Bleeding has no bad intentions — but it deserves a medical response. The functional and integrative medicine I practice is not an alternative to gynecological assessment. It comes after, it comes as a complement. But it never replaces it.
Once serious causes are ruled out — and statistically, this is the most probable case — it's time to consider overall hormonal balance. The drop in estrogen that accompanies menopause is not a simple trivial detail: it affects the endometrium, the vaginal mucosa, the skin, the bones, sleep, mood, and cognition. This is where micronutrition and targeted phytoestrogens can play a real role — not to treat bleeding, but to support the hormonal transition in its duration and complexity.
→ Read also: Menopause symptoms explained by a gynecologistFrequently Asked Questions
If it only bled once and very little, do I still need to consult?
Yes. Unequivocally. Abundance and frequency do not change the medical classification of the event: once you have been postmenopausal for 12 months or more, any episode of vaginal bleeding requires evaluation. A single, minimal bleed can be the first sign of very early-stage endometrial cancer — meaning at the time when treatment is most effective and prognosis is best.
My gynecologist told me it was probably vaginal atrophy. Is that reassuring?
If this diagnosis was made after a transvaginal ultrasound showing an endometrial thickness of less than 4-5 mm, and if no structural abnormalities were identified, yes — that's relatively good news. Endometrial or vaginal atrophy is the most common benign cause of PMB. It is effectively treated with local estrogen therapy (vaginal suppositories, cream, or ring), and non-hormonal alternatives exist for women who cannot use them.
If this diagnosis was made without imaging, based solely on clinical examination, request a transvaginal ultrasound. This is not distrust of your doctor. It is normal medical rigor in this context.
I am on HRT. Why am I bleeding unexpectedly?
With sequential combined HRT (estrogen + progesterone taken cyclically), withdrawal bleeding is expected and planned. However, bleeding outside these scheduled windows, or bleeding with continuous HRT (without interruption), should be reported to your doctor without delay. This may indicate a dosage imbalance, poor skin absorption, or, more rarely, endometrial pathology requiring imaging evaluation.
Can phytoestrogens cause postmenopausal bleeding?
This is a question I receive more and more in consultation, with the development of supplements containing red clover, Dong Quai, or soy isoflavones. The honest answer is: rarely, and at doses far above usual clinical dosages. Phytoestrogens exert a partial and modulated estrogenic action — structurally different from that of endogenous or exogenous estrogens, and without significant endometrial proliferation at common dosages. That said, if you are taking this type of supplement and you bleed, report it to your gynecologist so they can integrate it into their complete evaluation.
How do I know if the bleeding is coming from the vagina, urethra, or rectum?
It's not always easy to distinguish on your own, and that's precisely why a clinical examination is irreplaceable. What can help before the consultation: observe if the bleeding occurs when urinating (possible urological origin), during a bowel movement (possible anorectal origin), or spontaneously and independently of these two moments (probable genital origin). Note this context in your clinical diary — this information considerably speeds up the diagnosis during the consultation.
This article is for informational and educational purposes only. It does not replace personalized medical advice or a gynecological consultation. In case of vaginal bleeding after menopause, consult a gynecologist or doctor without delay.
Take care of your hormonal balance daily
Once your assessment is complete and serious causes are ruled out, the question of overall hormonal support remains. Nutremys' Menopause Vitality Complex is formulated to support women during perimenopause and menopause with targeted active ingredients — red clover, Dong Quai, Maca, and marine collagen — at clinical dosages, in a liquid formula with optimal bioavailability. At this age, approximation is no longer acceptable.
Discover the Menopause Vitality Complex →
